Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Werewolf Therapeutics Inc shares valued at $14,169 were purchased by MPM Asset Management LLC on Dec 10 ’25. At $1.01 per share, MPM Asset Management LLC acquired 14,029 shares.
Also, MPM Oncology Innovations Fund, purchased 19,519 shares, netting a total of over 19,714 in proceeds.
Before that, UBS Oncology Impact Fund, L.P. had added 73,195 shares to its account. In a trade valued at $73,927, the Shareholder bought Werewolf Therapeutics Inc shares for $1.01 each.
As published in their initiating research note from JMP Securities on April 03, 2024, Werewolf Therapeutics Inc [HOWL] has been a Mkt outperform and the price target has been revised to $12. Analysts at Wedbush started covering the stock with ‘”an Outperform”‘ outlook in a report released in late August. Earlier on September 10, 2021, BofA Securities initiated its rating. Their recommendation was “a Buy” for HOWL stock.
Analyzing HOWL Stock Performance
On last trading session, Werewolf Therapeutics Inc [NASDAQ: HOWL] rose 5.94% to $1.07. The stock’s lowest price that day was $0.96, but it reached a high of $1.11 in the same session. During the last five days, there has been a surge of approximately 16.57%. Over the course of the year, Werewolf Therapeutics Inc shares have dropped approximately -40.56%. Shares of the company reached a 52-week high of $2.3800 on 09/29/25 and a 52-week low of $0.5950 on 04/07/25.
Support And Resistance Levels for Werewolf Therapeutics Inc (HOWL)
According to the 24-hour chart, there is a support level at 0.9833, which, if violated, would cause prices to drop to 0.8967. In the upper region, resistance lies at 1.1333. The next price resistance is at 1.1967. RSI (Relative Strength Index) is 49.84 on the 14-day chart, showing neutral technical sentiment.
Is Werewolf Therapeutics Inc subject to short interest?
Stocks of Werewolf Therapeutics Inc saw a sharp rise in short interest on 2025-11-28 jumping by 0.12 million shares to 1.03 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 0.9 million shares. A jump of 11.94% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.53 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.53.
Which companies own the most shares of Werewolf Therapeutics Inc (HOWL)?
In terms of Werewolf Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, up nearly 1088.12% from the previous closing price of $1.01. Analysts anticipate Werewolf Therapeutics Inc stock to reach 12 by 2025, with the lowest price target being 12. In spite of this, 4 analysts ranked Werewolf Therapeutics Inc stock as Buy at the end of 2025. On May 25, 2021, SVB Leerink assigned a price target of “an Outperform” to the stock and initiated coverage with a $29.
